2012 Global H. Pylori Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country and Market Segment

April 2012 | 208 pages | ID: G9EAA3A9423EN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

• Hospitals
• Physician Offices
• Commercial/Private Labs
• Public Health Labs

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 208 pages and 9 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
   Pathogenesis
   Role in Peptic Ulcer Disease
   Role in Gastric Cancer
   Nonulcer Dyspepsia
B. Diagnostic Tests
C. Vaccines and Drugs
   Specific Therapeutic Regimens
   Who Should Be Treated?
   Participants in Controlled Clinical Trials
   Patients with Refractory Peptic Ulcer
   Patients with Refractory NUD
   Patients in High-Risk Groups for Gastric
Cancer
D. Instrumentation Review and Market Needs
   Abbott AxSYM
   Abbott IMx/IMx Select
   Anagen AN2000/AuraFlex
   Siemens Immuno 1
   Beckman Coulter Access
   BioChem Pharma/SR1
   BioMerieux/Vitek Vidas
   Biotrol System 7000
   Chiron ACS: Centaur
   Chiron ACS: 180
   Siemens ELISA Processor II/III
   Siemens/Opus/Plus/Magnum
   Siemens Stratus
   J&J Diagnostics Vitros ECi
   J&J Diagnostics/Amersham Amerlite
   Olympus PK310
   Roche Elecsys 1010/2010
   Roche Cobas Core
   Roche ES 300/300AL
   Roche ES 22
   Roche ES 33
   Tosoh AIA-1200/1200DX/NexIA/600
   Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
        Robotics
        Temperature Cyclers
        PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      Nucleic-Acid Sequence-Based
      Strand Displacement Activation
      Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassays
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Differential Light Scattering
  5. Microcomputers and Automation
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio-Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene-Tec
Hemagen
Immunetics
Innogenetics
Inverness
J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Helicobacter Pylori Tests
France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Testing Market Sales by Major Supplier